BioCentury
ARTICLE | Financial News

Foundation Medicine sets IPO range

September 13, 2013 12:25 AM UTC

Foundation Medicine Inc. (Cambridge, Mass.) amended its IPO and now plans to sell 5 million shares at $14-$16. At the $15 midpoint, the company would raise $75 million and be valued at $394.3 million. Goldman Sachs; JPMorgan; Leerink; and Sanford C. Bernstein are underwriters. In July, Foundation Medicine filed to raise up to $86.3 million in an IPO. ...